YaoGeJu

Company directoryChina company filings

Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

Complete CDE snapshot
2026/11/16 06:38
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/16 06:38.

Drug filings

4 acceptance records as first applicant, grouped into 2 source drug names. Source data as of 2026/11/16 06:38.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Fosfomycin Sodium For Injection 3 records · Latest accepted 2026/05/13

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2650116Supplement2026/05/13Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
CYHB2650115Supplement2026/05/13Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
CYHB2650114Supplement2026/05/13Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
Lacidipine Tablets 1 records · Latest accepted 2024/07/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450346Supplement2024/07/02Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

0 events from 2026/08/19 to 2026/11/16. CDE data as of 2026/11/16 06:38; NMPA data as of 2026/11/15 18:30.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/16 06:38.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Fosfomycin Sodium For Injection CYHB2650116Supplement2026/05/13Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
Fosfomycin Sodium For Injection CYHB2650115Supplement2026/05/13Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
Fosfomycin Sodium For Injection CYHB2650114Supplement2026/05/13Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗

Catalogue holder records

3 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/16 06:35. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Lacidipine TabletsHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized国药准字H109801802025/09/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Simvastatin TabletsHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized国药准字H200104542021/05/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amoxicillin CapsulesHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized国药准字H230232942021/04/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/16 06:37.

NameCompany / applicantRegistration numberStatusSource update dateView source
诺氟沙星 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20260000627I2026/08/07CDE ↗
硫酸艾沙康唑 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20250000303I2025/04/22CDE ↗
克立硼罗 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20240001304I2024/12/12CDE ↗
阿维巴坦钠 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20240000319A2026/06/25CDE ↗
乳酸钙 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20240000197A2025/10/14CDE ↗
蛋白琥珀酸铁 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20230001210A2026/02/04CDE ↗
盐酸罗沙替丁醋酸酯 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190008968A2024/07/05CDE ↗
对氨基水杨酸钠 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005816A2025/09/19CDE ↗
精氨酸 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005814A2025/09/19CDE ↗
辛伐他汀 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005390A2024/08/16CDE ↗
乳糖酸阿奇霉素 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005220A2025/09/19CDE ↗
酒石酸吉他霉素 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005186A2025/09/19CDE ↗
盐酸喹那普利 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005167A2025/09/18CDE ↗
拉西地平 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190005107A2025/07/19CDE ↗
缬沙坦 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190004383A2024/08/16CDE ↗
磷霉素钠 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190004363A2025/07/12CDE ↗
炎琥宁 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190004315A2025/07/05CDE ↗
烟酸占替诺 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190001327A2024/08/16CDE ↗
奥美拉唑钠 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190001326A2024/08/16CDE ↗
枸橼酸舍曲林 · No verified English nameHa Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedY20190001266A2024/08/16CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

5 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/16 06:38.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Aztreonam For Injection CYHB2650179Supplement2026/08/28Ha Yao Group Pharmaceutical Factory romanized; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
Aztreonam For Injection CYHB2650178Supplement2026/08/28Ha Yao Group Pharmaceutical Factory romanized; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
Aztreonam For Injection CYHB2650177Supplement2026/08/28Ha Yao Group Pharmaceutical Factory romanized; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
头孢拉定胶囊 · No verified English name CYHB2300896Supplement2023/04/26Ha Yao Group Pharmaceutical Factory romanized; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗
Cefalexin Capsules CYHB2300366Supplement2023/02/22Ha Yao Group Pharmaceutical Factory romanized; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanizedCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/16 06:38
Chemical-drug catalogue
Last successful update: 2026/11/16 06:35
Full API register
Last successful update: 2026/11/16 06:37
NMPA drug delivery notices
Last successful update: 2026/11/15 18:30

First index-page publication dates: 2026-10-29 to 2026-11-13; 0 pages pending. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.